250 related articles for article (PubMed ID: 28700501)
1. Metformin is associated with fewer major adverse cardiac events among patients with a new diagnosis of type 2 diabetes mellitus: A propensity score-matched nationwide study.
Lee KT; Yeh YH; Chang SH; See LC; Lee CH; Wu LS; Liu JR; Kuo CT; Wen MS
Medicine (Baltimore); 2017 Jul; 96(28):e7507. PubMed ID: 28700501
[TBL] [Abstract][Full Text] [Related]
2. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
[TBL] [Abstract][Full Text] [Related]
3. Metformin was associated with lower all-cause mortality in type 2 diabetes with acute coronary syndrome: A Nationwide registry with propensity score-matched analysis.
Jong CB; Chen KY; Hsieh MY; Su FY; Wu CC; Voon WC; Hsieh IC; Shyu KG; Chong JT; Lin WS; Hsu CN; Ueng KC; Lai CL
Int J Cardiol; 2019 Sep; 291():152-157. PubMed ID: 30905518
[TBL] [Abstract][Full Text] [Related]
4. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
[TBL] [Abstract][Full Text] [Related]
5. Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.
Hsiao PJ; Wu KL; Chiu SH; Chan JS; Lin YF; Wu CZ; Wu CC; Kao S; Fang TC; Lin SH; Chen JS
Clin Exp Nephrol; 2017 Aug; 21(4):694-704. PubMed ID: 27599981
[TBL] [Abstract][Full Text] [Related]
6. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
Heo E; Kim E; Jang EJ; Lee CH
BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
[TBL] [Abstract][Full Text] [Related]
7. Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.
Lee MC; Chiang CY; Lee CH; Ho CM; Chang CH; Wang JY; Chen SM
PLoS One; 2018; 13(10):e0205807. PubMed ID: 30335800
[TBL] [Abstract][Full Text] [Related]
8. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies.
Chang SH; Wu LS; Chiou MJ; Liu JR; Yu KH; Kuo CF; Wen MS; Chen WJ; Yeh YH; See LC
Cardiovasc Diabetol; 2014 Aug; 13():123. PubMed ID: 25106079
[TBL] [Abstract][Full Text] [Related]
9. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
Ou SM; Shih CJ; Chao PW; Chu H; Kuo SC; Lee YJ; Wang SJ; Yang CY; Lin CC; Chen TJ; Tarng DC; Li SY; Chen YT
Ann Intern Med; 2015 Nov; 163(9):663-72. PubMed ID: 26457538
[TBL] [Abstract][Full Text] [Related]
10. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
Tseng CH
Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
[TBL] [Abstract][Full Text] [Related]
11. Association of Metformin Use With End-Stage Renal Disease in Patients With Type 2 Diabetes Mellitus: A Nationwide Cohort Study Under the Pay-for-Performance Program.
Lee MC; Lee CH; Chang LY; Chang CH; Zhang JF; Lee MR; Wang JY; Chen SM
J Clin Pharmacol; 2019 Nov; 59(11):1443-1452. PubMed ID: 31163098
[TBL] [Abstract][Full Text] [Related]
12. Effect of metformin monotherapy on cardiovascular diseases and mortality: a retrospective cohort study on Chinese type 2 diabetes mellitus patients.
Fung CS; Wan EY; Wong CK; Jiao F; Chan AK
Cardiovasc Diabetol; 2015 Oct; 14():137. PubMed ID: 26453464
[TBL] [Abstract][Full Text] [Related]
13. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
Tseng CH
Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
[TBL] [Abstract][Full Text] [Related]
14. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
Tseng CH
Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
[TBL] [Abstract][Full Text] [Related]
15. The effects of dual-therapy intensification with insulin or dipeptidylpeptidase-4 inhibitor on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A retrospective cohort study.
Jil M; Rajnikant M; Richard D; Iskandar I
Diab Vasc Dis Res; 2017 Jul; 14(4):295-303. PubMed ID: 28330386
[TBL] [Abstract][Full Text] [Related]
16. Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study.
Huang TL; Hsiao FY; Chiang CK; Shen LJ; Huang CF
PLoS One; 2019; 14(5):e0215248. PubMed ID: 31112536
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus.
Kuan YC; Huang KW; Lin CL; Hu CJ; Kao CH
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):77-83. PubMed ID: 28583443
[TBL] [Abstract][Full Text] [Related]
18. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.
Tsai MJ; Yang CJ; Kung YT; Sheu CC; Shen YT; Chang PY; Huang MS; Chiu HC
Lung Cancer; 2014 Nov; 86(2):137-43. PubMed ID: 25267165
[TBL] [Abstract][Full Text] [Related]
19. Metformin is associated with a lower risk of active tuberculosis in patients with type 2 diabetes.
Lin SY; Tu HP; Lu PL; Chen TC; Wang WH; Chong IW; Chen YH
Respirology; 2018 Nov; 23(11):1063-1073. PubMed ID: 29943489
[TBL] [Abstract][Full Text] [Related]
20. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis.
Kalsekar ID; Madhavan SS; Amonkar MM; Douglas SM; Makela E; Elswick BL; Scott V
Clin Ther; 2006 Feb; 28(2):306-18. PubMed ID: 16678652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
